H. Worth (Furth, Germany), N. Miculinic (Zagreb, Croatia)
LATE-BREAKING ABSTRACT: Effect of inhalation of tobramycin on reduction of hospitalisation rate in severe COPD
P. Haidl (Schmallenberg, Germany)
|   |
LATE-BREAKING ABSTRACT: Discharge coordinator intervention prevents hospitalisations in patients with COPD: A randomized controlled trial
M. Lainscak, S. Kadivec, M. Kosnik, B. Benedik, M. Bratkovic, T. Jakhel, R. Marcun, P. Miklosa, B. Stalc, J. Farkas (Golnik, Ljubljana, Slovenia)
| |
QVA149 administered once daily provides significant improvements in lung function over 1 year in patients with COPD: The ENLIGHTEN study
R. Dahl, K. Chapman, M. Rudolf, R. Mehta, P. Kho, V. Alagappan, I. Berhane, H. Chen, D. Banerji (Aarhus, Denmark; Toronto, Canada; London, Horsham, United Kingdom; Indore, India; East Hanover, United States Of America)
| |
Pneumonia in COPD patients treated with fixed ICS/LABA combinations
C. Janson, K. Larsson, K. Lisspers, B. Ställberg, G. Stratelis, G. Telg, L. Jörgensen, G. Johansson (Uppsala, Stockholm, Södertälje, Sweden)
| |
Estimates of demand and use for home oxygen for COPD in England and Wales
G. Donaldson, J. Wedzicha, H. Jamil, K. Holton, S. Hill (London, United Kingdom)
| |
Target lobar volume reduction and COPD outcome measures after endobronchial one-way valve therapy
A. Valipour, F.J.F. Herth, G.J. Criner, J.M. Vergnon, J. Goldin, F. Sciurba, A. Ernst (Vienna, Austria; Heidelberg, Germany; Philadelphia, Los Angeles, , Boston, United States Of America; Saint Etienne, France)
| |
Sustaining a chronic obstructive pulmonary disease (COPD) discharge care bundle on the respiratory ward in an acute district general hospital
B. Mann, E. Ramhamadany, L. Flores, A. Mngadi, L. Eapen, H. Venturina, S. Wilson, M. Pasha, R. Tidswell (London, United Kingdom)
| |
The six-minute walking test in patients with severe COPD: What conditions are matters?
M. Sanzharovskaya, A. Fisenko, G. Chernogoryuk, K. Zavadovskiy (Tomsk, Russian Federation)
| |
Hospital admitted COPD patients treated at home using telemedicine technology – A randomized, multi-centre trial
A.S. Jakobsen, L.C. Laursen, B. Østergaard, S. Rydahl-Hansen, C. Emme, L. Schou, K.V. Phanareth (Frederiksberg, Herlev, Odense, Bispebjerg, Denmark)
| |
COPD self management: The impact of implementing self management plans & rescue medications across 3 hospitals
H. Khachi, M. Hodson, R. Hudson, M. Parker (London, Essex, United Kingdom)
| |
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Y. Kusunoki, R. Furutate, K. Hattori, T. Ishii, T. Motegi, K. Yamada, A. Gemma, K. Kida (Tokyo, Japan)
| |
Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease
A. Porcu, S. Balestracci, M. Polselli, B. Marsiglia, FIMMG Progetto MITO, A. Macuzzi, P.C. Rossi, M. Moretti (Carrara, Italy)
| |
Cardioselective beta-blockers are not only safe in patients with COPD, but may also improve the responsibility of FEV1 to beta-agonist: A meta-analysis of randomized controlled double-blinded trials
Y. Ni, G. Shi (Shanghai, China)
| |
Continuance and effects of self-training at home using a bicycle ergometer with long-term oxygen therapy
Y. Kusunoki, R. Wakabayashi, K. Hattori, T. Ishii, R. Furutate, T. Motegi, K. Yamada, A. Gemma, K. Kida (Tokyo, Japan)
| |
COPD: Disease coping styles
Y. Galetskayte, D. Pushkarev, S. Ovcharenko, B. Volel (Moscow, Russian Federation)
| |
Disease management program for COPD patients with frequent exacerbations
A. Marin, M. Rivera, G. Bonet, R. Hervas, L. Merlos, J. Ruiz-Manzano (Badalona, Spain)
| |
Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy
Y. Wang, L. Tao, G. Shi, H. Wan, X. Cai, H. Zhu (Shanghai, China)
| |
Multiple dimensional analysis of arterial blood gas and pulmonary function in patients with COPD
T. Takahashi, S. Muro, S. Sato, Y. Fuseya, N. Tanabe, Y. Hoshino, E. Ogawa, M. Mishima (Kyoto, Shiga, Japan)
| |